BioStar Ventures
PE / VC
2005
$286 M
Charlevoix, Michigan, United States
Profile
BioStar Capital is a venture capital firm based in Charlevoix, Michigan, founded in 2005. The firm is led by a team of healthcare clinicians, medical thought leaders, and financial professionals, focusing on transformative medical technologies. BioStar Capital is known for its unique collaboration between clinical expertise and business acumen, which has consistently produced life-changing outcomes for patients and rewarding returns for investors.
The firm invests primarily in the medical technology sector, including surgical and therapeutic devices. BioStar Capital typically participates in early to late-stage investments, with a focus on North America. The firm manages several funds, including BioStar Ventures V, which closed in 2021. BioStar Capital's strategic partners and limited partners include leading healthcare institutions and industry experts.
Notable investments by BioStar Capital include Amplitude Vascular Systems - developer of the Pulse IVL platform, Field Medical - surgical devices, Nectero Therapeutics - therapeutic devices, REVA Medical - therapeutic devices, Versa Vascular - therapeutic devices, and Medical Microinstruments - surgical devices.
Industry
BioStar Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
BioStar Capital Fund III
|
Venture Capital (VC)
|
Healthcare Services
Medical Devices
Robotics
Software
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$68 M
|
July 2015
|
|
BioStar Ventures V
|
Private Equity (PE)
Venture Capital (VC)
|
Biotechnology
Electronics
Healthcare Services
Medical Devices
Robotics
Gaming
Other
MedTech
Technology
Life Sciences
Infrastructure
HealthTech
|
Series A
Seed
Series B
Late Stage (Series C+)
|
North America
|
$1-5 m
|
—
|
January 2021
|
